Skip to content

Prospective Agreement Study of Magnetic Resonance Imaging Measurements and Intraoperative Dimensions During Gluteal Permanent Synthetic Filler Removal

Prospective Agreement Study of Magnetic Resonance Imaging Measurements and Intraoperative Dimensions During Gluteal Permanent Synthetic Filler Removal

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07808996
Enrollment
220
Registered
2026-09-09
Start date
2026-10-01
Completion date
2027-12-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foreign-Body Reaction, Gluteal Tissue Ischemia Risk, Soft Tissue Filler Complication

Keywords

Gluteal Reconstruction, Specimen Measurement, Flap Thickness, Surgical Planning, Magnetic Resonance Imaging, Biopolymers

Brief summary

This prospective agreement study will compare preoperative MRI measurements with direct surgical measurements in adults undergoing removal of gluteal tissue affected by permanent synthetic fillers. MRI will estimate affected-tissue dimensions and residual skin-flap thickness at predefined landmarks. During surgery, the same flap landmarks and the fresh excised specimen will be measured. The primary outcome is agreement between MRI and intraoperative flap thickness; postoperative ischemia, wound dehiscence, and necrosis will be followed through 30 days.

Detailed description

Participants will receive standardized preoperative MRI morphometric mapping within 90 days before surgery. Two trained readers will measure the affected tissue block in three axes, estimate its volume, and record residual flap thickness at predefined surface landmarks. During the index filler-removal procedure, the landmarks will be reproduced and measured directly with a calibrated sterile device. The fresh specimen will be oriented, measured, and weighed before fixation. Agreement, bias, and prediction error will be quantified. Clinical follow-up through day 30 will determine whether thinner flaps or larger prediction errors are associated with ischemia-related wound complications.

Interventions

DIAGNOSTIC_TESTPreoperative MRI Morphometric Mapping

Three orthogonal dimensions of the affected block and residual flap thickness at fixed surface landmarks will be measured on MRI by two trained readers. Affected-tissue volume will be estimated using segmentation when available and a prespecified geometric approximation otherwise. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.

PROCEDUREStandardized Intraoperative and Fresh-Specimen Measurement

Before closure, residual flap thickness will be measured with a calibrated sterile device at the same mapped landmarks without compressing the tissue. The fresh excised block will be oriented and measured in three axes before fixation. Specimen weight will also be recorded. Linked arm/group(s): MRI-to-Surgery Agreement Cohort.

Sponsors

Research Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older. * Gluteal permanent synthetic filler disease scheduled for elective surgical excision. * Preoperative MRI performed within 90 days before surgery using the study measurement protocol. * Planned skin/subcutaneous flap elevation that permits direct thickness measurement at predefined landmarks. * Written informed consent.

Exclusion criteria

* Emergency surgery or active uncontrolled infection that prevents standardized preoperative imaging or measurement. * Prior surgery causing loss of the predefined landmarks or making paired measurement impossible. * Nondiagnostic MRI or incomplete coverage of the planned operative field. * Specimen fragmentation that prevents standardized fresh-specimen dimension measurement for the secondary endpoint. * Inability to complete 30-day wound follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Agreement Between MRI and Intraoperative Residual Flap ThicknessPreoperative MRI within 90 days before surgery and the index surgical procedure. 90 daysResidual skin-subcutaneous flap thickness in millimeters will be measured at predefined mapped landmarks on MRI and directly during surgery. Agreement will be summarized using intraclass correlation, mean bias, 95% limits of agreement, and absolute error.

Secondary

MeasureTime frameDescription
Agreement Between MRI and Fresh-Specimen Affected-Tissue DimensionsPreoperative MRI within 90 days before surgery and immediately after specimen removal during the index operation. 90 daysMaximum craniocaudal, mediolateral, and anteroposterior dimensions in centimeters will be compared between MRI and the oriented fresh specimen before fixation.
Absolute Percentage Error in Predicted Affected-Tissue VolumePreoperative MRI and the index surgical procedure. 1 dayAbsolute difference between MRI-predicted and specimen-derived volume divided by specimen-derived volume and multiplied by 100. Lower values indicate more accurate prediction.
Incidence of Ischemic Wound ComplicationsFrom surgery through postoperative day 30. 30 daysProportion of participants with clinically documented flap ischemia, partial- or full-thickness tissue necrosis, or wound dehiscence judged to be related to tissue perfusion.

Contacts

CONTACTEdison Osorio, MD, Plastic surgeon
info@edisonosorio.com+573226140611
PRINCIPAL_INVESTIGATOREdison Osorio, MD, plastic surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026